<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> stroma plays an important role in the progression of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Although alterations in miRNA expression have been explored in various kinds of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, the expression of miRNAs in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stroma has not been explored in detail </plain></SENT>
<SENT sid="2" pm="."><plain>EXPERIMENTAL DESIGN: Using a laser microdissection technique, we collected <z:chebi fb="40" ids="33697">RNA</z:chebi> samples specific for epithelium or stroma from 13 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissues and four <z:mpath ids='MPATH_458'>normal</z:mpath> tissues, and miRNA microarray and gene expression microarray were carried out </plain></SENT>
<SENT sid="3" pm="."><plain>The expression status of miRNAs was confirmed by reverse transcriptase PCR </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, we investigated whether miRNA expression status in stromal tissue could influence the clinicopathologic factors </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Oncogenic miRNAs, including two miRNA clusters, miR-17-92a and miR-106b-25 cluster, were upregulated in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stromal tissues compared with <z:mpath ids='MPATH_458'>normal</z:mpath> stroma </plain></SENT>
<SENT sid="6" pm="."><plain>Gene expression profiles from cDNA microarray analyses of the same stromal tissue samples revealed that putative targets of these miRNA clusters, predicted by Target Scan, such as TGFBR2, SMAD2, and BMP family genes, were significantly downregulated in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stromal tissue </plain></SENT>
<SENT sid="7" pm="."><plain>Downregulated putative targets were also found to be involved in cytokine interaction and cellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Importantly, expression of miR-25 and miR-92a in stromal tissues was associated with a variety of clinicopathologic factors </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Oncogenic miRNAs were highly expressed in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stroma </plain></SENT>
<SENT sid="10" pm="."><plain>Although further validation is required, the finding that stromal miRNA expression levels were associated with clinicopathologic factors suggests the possibility that miRNAs in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stroma are crucially involved in <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">cancer progression</z:e> </plain></SENT>
</text></document>